Blue Crest Capital Management LTD Bristol Myers Squibb CO Transaction History

Blue Crest Capital Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $2.53 Million - $2.87 Million	-52,701 Reduced 89.23%	6,364 $345,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $1.96 Million - $2.34 Million	40,501 Added 218.17%	59,065 $3.03 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $1.07 Million - $1.2 Million	18,564 New	18,564 $1.08 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $283,744 - $370,119	-5,766 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $315,941 - $374,594	-7,387 Reduced 56.16%	5,766 $292,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $78,796 - $102,179	-1,616 Reduced 10.94%	13,153 $684,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $70,919 - $79,991	1,285 Added 9.53%	14,769 $917,000
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $681,346 - $849,222	13,484 New	13,484 $746,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.